Denmark: A recent randomized clinical trial, VAXAK, has highlighted the potential benefits of human papillomavirus (HPV) ...

weakened immune responses to HPV in the skin increase the risk of actinic keratosis (AK) and skin cancer. Our findings reveal an innovative therapeutic strategy that promotes anti-HPV T cell ...